http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6345270-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
filingDate 1987-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267194b28e92d67786409e408d174ce6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08371a19d0d2f12c3a131e895454cac5
publicationDate 1988-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6345270-A
titleOfInvention 1,4-benzoxazine derivative, production thereof and pharmaceutical composition containing same
abstract NEW MATERIAL:The compound of formula I [R 1 and R 2 are H, halogen, NO 2 , alkyl, amino, OH, alkoxycarbonyl or together form (CH 2 ) m (m is 3W5) or O-(CH 2 ) n -O (n is 1W3); R 3 is H or alkyl; R 4 and R 5 are H, halogen, alkyl or OH; A is alkylene] or its acid addition salt. n EXAMPLE: 2-{3-[4-(4-Fluorophenyl)-1-piperazinyl]-propyl}-6, 7, 8, 9-tetrahydro-2H- naphtho[2,3-b][1,4]-oxazin-3(4H)-one. n USE: A drug having strong hypotensive and vasodilating action, etc. n PREPARATION: The compound of formula I can be produced e.g. by reacting the compound of formula II (X is eliminable group) with the compound of formula III in the presence of a proper acid acceptor 50W150°C. n COPYRIGHT: (C)1988,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011513431-A
priorityDate 1986-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420589119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419921794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14304651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15246252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235894491

Total number of triples: 32.